Published in Essays Neurochem Neuropharmacol on January 01, 1978
Biphasic effect of direct GABA mimetic drugs on haloperidol-induced catalepsy [proceedings]. Br J Pharmacol (1979) 0.75
Biochemical evidence of dysfunction of brain neurotransmitters in the Lesch-Nyhan syndrome. N Engl J Med (1981) 1.48
The neurochemistry of Parkinson's disease: effect of L-dopa therapy. J Pharmacol Exp Ther (1975) 1.28
Upregulation of gamma-aminobutyric acid (GABA) B binding sites in rat frontal cortex: a common action of repeated administration of different classes of antidepressants and electroshock. J Pharmacol Exp Ther (1985) 1.20
Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects. J Pharmacol Exp Ther (1986) 1.19
Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. II. Evidence for N-methyl-D-aspartate receptor antagonist properties. J Pharmacol Exp Ther (1988) 1.10
Alterations of GABA-mediated synaptic transmission in human epilepsy. Adv Neurol (1986) 1.08
Quinolinic-phosphoribosyl transferase activity is decreased in epileptic human brain tissue. Epilepsia (1988) 1.01
Ifenprodil and SL 82.0715 as cerebral antiischemic agents. III. Evidence for antagonistic effects at the polyamine modulatory site within the N-methyl-D-aspartate receptor complex. J Pharmacol Exp Ther (1990) 1.01
Sulphasalazine and PhCL28A inhibit the formation of ethanol- and phenylbutazone-induced rat gastric ulcers: lack of involvement of endogenous prostaglandins? Br J Pharmacol (1988) 0.97
Serotonin and 5-hydroxyindoleacetic acid in discrete areas of the brainstem of suicide victims and control patients. Adv Biochem Psychopharmacol (1974) 0.96
L-glutamic acid decarboxylase in Parkinson's disease: effect of L-dopa therapy. Nature (1973) 0.95
Chronic antidepressants and GABA "B" receptors: a GABA hypothesis of antidepressant drug action. Life Sci (1984) 0.95
GABA involvement in neuroleptic-induced catalepsy. J Pharm Pharmacol (1978) 0.94
gamma-Aminobutyric acid (GABA) receptor stimulation. II. Specificity of progabide (SL 76002) and SL 75102 for the GABA receptor. J Pharmacol Exp Ther (1982) 0.93
Familial fatal Parkinsonism with alveolar hypoventilation and mental depression. Ann Neurol (1979) 0.91
Pharmacological and behavioral profile of alpidem as an anxiolytic. Pharmacopsychiatry (1990) 0.91
Striatonigral degeneration. Response to levodopa therapy with pathological and neurochemical correlation. J Neurol Sci (1973) 0.91
CNS compensation to dopamine neuron loss in Parkinson's disease. Adv Exp Med Biol (1977) 0.90
gamma-Aminobutyric acid (GABA) receptor stimulation. III. Effect of progabide (SL 76002) on norepinephrine, dopamine and 5-hydroxytryptamine turnover in rat brain areas. J Pharmacol Exp Ther (1982) 0.88
gamma-Aminobutyric acid (GABA) receptor stimulation. I. Neuropharmacological profiles of progabide (SL 76002) and SL 75102, with emphasis on their anticonvulsant spectra. J Pharmacol Exp Ther (1982) 0.88
Distribution of choline acetyltransferase and glutamate decarboxylase within the substantia nigra and in other brain regions from control and Parkinsonian patients. J Neurochem (1975) 0.87
Occurrence and distribution of aromatic L-amino acid (L-DOPA) decarboxylase in the human brain. J Neurochem (1972) 0.87
The potential use of GABA agonists in psychiatric disorders: evidence from studies with progabide in animal models and clinical trials. Pharmacol Biochem Behav (1983) 0.85
Acetylcholine release within the cat striatum during the sleep-wakefulness cycle. Nature (1973) 0.84
Enhanced striatal acetylcholine release by chlorpromazine and its reversal by apomorphine. Brain Res (1973) 0.84
New anticonvulsants: Schiff bases of gamma-aminobutyric acid and gamma-aminobutyramide. J Med Chem (1980) 0.84
An analysis of [3H]gamma-aminobutyric acid (GABA) binding in the human brain. Brain Res (1979) 0.83
Fengabine, a novel antidepressant GABAergic agent. I. Activity in models for antidepressant drugs and psychopharmacological profile. J Pharmacol Exp Ther (1987) 0.82
[GABAergic theory of epilepsy]. Rev Prat (1986) 0.81
Fengabine, a novel antidepressant GABAergic agent. II. Effect on cerebral noradrenergic, serotonergic and GABAergic transmission in the rat. J Pharmacol Exp Ther (1987) 0.81
Selectivity for omega-receptor subtypes as a strategy for the development of anxiolytic drugs. Pharmacopsychiatry (1990) 0.81
Cortical modulation of striatal function. Brain Res (1982) 0.81
The use of the push-pull cannula to estimate the dynamics of acetylcholine and catecholamines within various brain areas. Neuropharmacology (1976) 0.81
Dopaminergic inhibition of striatal cholinergic neurons: synergistic blocking action of gamma-butyrolactone and neuroleptic drugs. Naunyn Schmiedebergs Arch Pharmacol (1974) 0.81
[3H]GABA binding in brains from Huntington's chorea patients: altered regulation by phospholipids? Science (1979) 0.80
Effects of the GABA receptor agonist, progabide, upon local cerebral glucose utilization. Brain Res (1987) 0.80
Catecholamine and octopamine concentrations in brains of patients with Reye syndrome. Neurology (1977) 0.80
Influence of GABA-agonists and antagonists on neuroleptic-induced catalepsy in rats. Life Sci (1978) 0.79
Evidence that clomethiazole interacts with the macromolecular GABA A-receptor complex in the central nervous system and in the anterior pituitary gland. Naunyn Schmiedebergs Arch Pharmacol (1989) 0.79
Sustained gamma-aminobutyric acid receptor stimulation and chronic neuroleptic effects. Adv Biochem Psychopharmacol (1980) 0.78
GABA receptor agonists and extrapyramidal motor function: therapeutic implications for Parkinson's disease. Adv Neurol (1987) 0.78
Neuropharmacological spectrum of muscimol. Life Sci (1979) 0.78
Akinesia after locally applied morphine near the nucleus raphe pontis of the rat. Neurosci Lett (1984) 0.78
Interactions between GABA, dopamine, acetylcholine, and glutamate-containing neurons in the extrapyramidal and limbic systems. Adv Biochem Psychopharmacol (1981) 0.78
Anti-apomorphine effects of phenothiazine drug metabolites. Psychopharmacology (Berl) (1987) 0.77
Tribute: Arvid Carlsson and Oleh Hornykiewicz: Oleh Hornkiewicz. Adv Biochem Psychopharmacol (1977) 0.77
CSF gradients for amino acid neurotransmitters. J Neurol Neurosurg Psychiatry (1988) 0.77
Non-benzodiazepine anxiolytics: potential activity of phenylpiperazines without 3H-diazepam displacing action. Pharmacol Biochem Behav (1985) 0.77
Biochemical neuroanatomy of the human substantia nigra (pars compacta) in normal and Parkinsonian subjects. Adv Neurol (1982) 0.77
Involvement of the amygdala in the effect of antidepressants on the passive avoidance deficit in bulbectomised rats. Psychopharmacology (Berl) (1981) 0.77
The role of GABA mediated neurotransmission in convulsive states. Adv Biochem Psychopharmacol (1981) 0.77
Neurochemical and neuropharmacological indications for the involvement of GABA and glycine receptors in neuropsychiatric disorders. Adv Biochem Psychopharmacol (1983) 0.76
Neuropharmacological actions of GABA agonists: predictability for their clinical usefulness. Adv Biochem Psychopharmacol (1981) 0.76
The effect of drugs on the release of endogenous catecholamines into the perfusate of discrete brain areas of the cat in vivo. Experientia (1975) 0.76
Decreased GABA B receptors in helpless rats: reversal by tricyclic antidepressants. Neuropsychobiology (1989) 0.76
Biphasic effects of direct, but not indirect, GABA mimetics and antagonists on haloperidol-induced catalepsy. Naunyn Schmiedebergs Arch Pharmacol (1980) 0.76
Pharmacological and therapeutic actions of GABA receptor agonists. J Neural Transm Suppl (1983) 0.76
Cerebrospinal fluid amino acid and monoamine metabolite levels of Papio papio: correlation with photosensitivity. Brain Res (1986) 0.76
Comparative rheological profile of rat gastric and duodenal gel mucus. Biorheology (1989) 0.76
Glycine receptors in the human substantia nigra as defined by [3H]strychnine binding. J Neurochem (1982) 0.76
Predictability and specificity of behavioral screening tests for neuroleptics. Pharmacol Ther B (1979) 0.76
The effects of N-methyl-D-aspartate and kainate lesions of the rat striatum on striatal ornithine decarboxylase activity and polyamine levels. Brain Res (1991) 0.76
Sodium-independent, high-affinity binding of [3H]gamma-aminobutyric acid in human neurological disorders. Adv Exp Med Biol (1979) 0.76
Enhanced effect of haloperidol and apomorphine after hypophysectomy: pharmacokinetic considerations. J Pharm Pharmacol (1983) 0.76
The effect of methiothepin on cerebral monoamine neurons. Adv Biochem Psychopharmacol (1974) 0.76
Psychiatric disturbances occurring during levodopa therapy of Parkinson's disease. Prim Care (1977) 0.75
Alterations in 3H-GABA binding in Huntington's chorea. Life Sci (1977) 0.75
GABA receptors distribution in rat substantia nigra. Neurosci Lett (1981) 0.75
Biphasic effect of direct GABA mimetic drugs on haloperidol-induced catalepsy [proceedings]. Br J Pharmacol (1979) 0.75
[Implications of GABAergic synapses in neuropsychiatry]. J Pharmacol (1985) 0.75
Role of GABAergic systems in the mechanism of action of antiepileptic drugs. Therapie (1984) 0.75
Indications for the use of gamma-aminobutyric acid (GABA)-agonists in convulsant disorders. Prog Clin Biol Res (1983) 0.75
Induction and reversal of dopamine dyskinesia in rat, cat, and monkey. Psychopharmacology Suppl (1985) 0.75
Characterization of the nipecotic binding to rat brain membranes. Gen Pharmacol (1993) 0.75
Cobalt injections into the substantia nigra of the rat: effects on behavior and dopamine metabolism in the striatum. Exp Neurol (1978) 0.75
Effect of chronic neuroleptic or L-DOPA administration on GABA levels in the rat substantia nigra. Life Sci (1977) 0.75
The neuropathology of GABA neurons in extrapyramidal disorders. J Neural Transm Suppl (1980) 0.75
GABA synapses, depression, and antidepressant drugs. Psychopharmacol Ser (1987) 0.75
Study on the effect of oral administration of carbocysteine on ventilatory parameters in the SO2 inhalation model of bronchitis in the rat. Fundam Clin Pharmacol (1992) 0.75
Special chemistry of the basal ganglia 2. Distribution of acetylcholine, choline acetyltransferase and acetylcholinesterase. Pharmacol Ther B (1975) 0.75
Involvement of caudate nucleus, amygdala or reticular formation in neuroleptic and narcotic catalepsy. Pharmacol Biochem Behav (1981) 0.75
Gamma-aminobutyric-acid analogues. Lancet (1978) 0.75
Special chemistry of the basal ganglia I. Monoamines. Pharmacol Ther B (1975) 0.75
Failure to evoke ictal discharges by metrazol activation in cats with an experimentally induced mild amygdaloid focus. Exp Neurol (1975) 0.75
Kinetics of L-DOPA metabolism in the caudate nucleus of cats with ventrotegmental lesions. J Neural Transm Suppl (1980) 0.75
Subchronic administration of GABAergic agonists elevates [3H]GABA binding and produces tolerance in striatal dopamine catabolism. Brain Res (1985) 0.75
Differential blockade of bicuculline convulsions by neuroleptics. Eur J Pharmacol (1978) 0.75
The GABA hypothesis of depression and antidepressant drug action. Psychopharmacol Bull (1985) 0.75
The comparative effects of benzodiazepines, progabide and PK 9084 on acquisition of passive avoidance in mice. Psychopharmacology (Berl) (1984) 0.75
The potential of GABA-mimetics in the therapy of extrapyramidal disorders. J Neural Transm Suppl (1980) 0.75
Experimental midbrain lesions: neurochemical comparison between the animal model and Parkinson's disease. Brain Res (1971) 0.75
Chronic neuroleptic therapy: tolerance and GABA systems. Adv Biochem Psychopharmacol (1977) 0.75
The effect of different types of cortical lesions on drug-induced catalepsy in rats: a pharmacological analysis. Eur J Pharmacol (1985) 0.75
Characterization of the calcium and chloride [3H]glutamate binding site in crude synaptic membranes from human brain tissue. Gen Pharmacol (1993) 0.75
Interaction of dopaminergic and cholinergic neurons in the extrapyramidal and limbic systems. Adv Biochem Psychopharmacol (1977) 0.75
A new ex vivo method for the study of nasal drops on ciliary function. Fundam Clin Pharmacol (1989) 0.75
Levodopa in the treatment of Parkinson's disease. Prim Care (1977) 0.75
Cortical and subcortical projected foci in cats: inhibitory action of taurine. Neurology (1975) 0.75
Ethyl alcohol on escape from electrical periaqueductal gray stimulation in rats. Pharmacol Biochem Behav (1984) 0.75
[Amino acids in human epileptogenic foci]. Neurochirurgie (1986) 0.75